LUT014 works by paradoxically reactivating MAPK, a key signaling pathway in the skin that anti-EGFR therapies shut down.

Velsera and Complete Genomics are expanding their ability to serve clinical labs with an end-to-end solution from sample to ...

Researchers have developed a new gene expression atlas to map how abnormal differentiation of hematopoietic cells can lead to acute myeloid leukemia (AML).

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

A fundamental discovery in how the immune system organizes itself to respond better to external threats,” researchers find in study.

University of Pittsburgh scientists working with UPMC infection preventionists have developed an infectious diseases detection platform that, over a two-year trial, was found to stop outbreaks, save ...

AACR conference chairs Lillian L. Siu, MD, and Matthew Vander Heiden, MD, PhD, share their perspectives on the event with GEN ...

Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.

Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...

Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

FUJIFILM has invested about $4 billion in building biopharmaceutical manufacturing sites and life sciences capabilities.

Revvity and Watchmaker Genomics are working to bring more flexible and scalable NGS solutions to researchers worldwide.